Mefenamic Acid Capsule
Product Images NDC 68180-185

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mefenamic Acid (NDC 68180-185). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7c045941 1f44 4f8c 83a0 Fda2e962037f 01

Chemical structure of Mefenamic Acid, showing a benzene ring attached to a carboxyl group (COOH) and an amine group (NH) linked to a dimethyl-substituted benzene ring.*

FDA Label Image

7c045941 1f44 4f8c 83a0 Fda2e962037f 02

Label for Mefenamic Acid Capsules USP 250 mg, containing 30 capsules. This oral prescription drug is labeled with NDC 68180-185, manufactured by Lupin Pharmaceuticals, Inc. and Lupin Limited. The label includes dosing information, storage instructions, and a barcode, with emphasis on dispensing with the medication guide provided to each patient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.